• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Biotech

    Biomea Fusion Starts Phase 2 for Type 2 Diabetes Patients

    GLOBENEWSWIRE

    Biomea Fusion Unveils 2025 Financials And Corporate Highlights

    GLOBENEWSWIRE

    Biomea Fusion Presents COVALENT-111 Phase 2 T2D Data at ATTD 2026

    GLOBENEWSWIRE

    Biomea Fusion Focuses On Key Icovamenib And BMF-650 Milestones

    GLOBENEWSWIRE

    Biomea Fusion Presents Menin And Icovamenib Data At WCIRDC 2025

    GLOBENEWSWIRE

    Biomea Fusion Unveils COVALENT-111 Study Results At WCIRDC

    GLOBENEWSWIRE

    Biomea Fusion Presents Icovamenib At WCIRDC 23Rd World Congress

    GLOBENEWSWIRE

    Biomea Fusion To Present At Jefferies London Healthcare Conf

    GLOBENEWSWIRE

    Biomea Fusion Highlights Preclinical Progress Of BMF-650

    GLOBENEWSWIRE

    Biomea Fusion Unveils Q3 2025 Financials & Key Achievements

    GLOBENEWSWIRE

    Biomea Fusion Joins Citi`s SMID Biotech Fireside Chat

    GLOBENEWSWIRE

    Biomea Fusion Shows Icovamenib Improves Blood Sugar In T2D

    EXPRESSPHARMA

    Biomea Fusion Reveals Positive Phase II Results For Icovamenib

    GLOBENEWSWIRE

    Biomea Fusion Shows Icovamenib`s Synergy with Semaglutide in T2D

    GLOBENEWSWIRE

    Biomea Fusion Reports Preclinical Data for BMF-650 Showing Weight

    GLOBENEWSWIRE

    Biomea cuts staff, drops leukemia asset in metabolic shift

    FIERCE BIOTECH

    Biomea Fusion Reports 2024 Financial Results and Highlights

    GLOBENEWSWIRE

    Biomea Fusion Announces Leadership Transition

    GLOBENEWSWIRE

    Biomea Reports Preclinical Data On Icovamenib-Semaglutide Study

    GLOBENEWSWIRE

    Biomea Fusion to Present at the 43rd Annual J.P. Morgan Conference

    GLOBENEWSWIRE

    Biomea`s diabetes drug improves glucose control in ph. 2 trial

    FIERCE BIOTECH

    Biomea Preclinical Data Icovamenib Enhance Effectiveness of GLP-1

    GLOBENEWSWIRE

    Biomea Fusion Presents +VE Data from Initial Cohorts of the Ongoing Ph II Study of BMF-219

    GLOBENEWSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.